Israel

As life sciences investors shy away from drug development and opt for lower-risk devices and diagnostics, what can Europe learn from Israel’s experience?

After a week when the media were full of ideas for developing safer nanotechnology, one country leaps into the vanguard with a programme to develop weapons based on nanotechnology.